Web Date: October 12, 2017
Big pharma joins NIH’s Cancer Moonshot for a biomarker hunt
Eleven drug companies are joining forces with the National Institutes of Health’s Cancer Moonshot mission to deliver immunotherapy to more patients in less time. A partnership launched today will expedite the discovery of cancer immunotherapy biomarkers, molecular bar codes that help doctors know how to treat a tumor and gauge how well a patient responds to a drug.
The Cancer Moonshot Task Force was initiated by former President Barack Obama in February 2016 and initially . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society